Standout Papers

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance 2020 2026 2022 2024429
  1. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance (2020)
    Maddison Rose, Joshua T. Burgess et al. Frontiers in Cell and Developmental Biology

Immediate Impact

6 by Nobel laureates 28 from Science/Nature 82 standout
Sub-graph 1 of 23

Citing Papers

NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance
2024 StandoutNature
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
10 intermediate papers

Works of Emma Bolderson being referenced

INTS3 controls the hSSB1-mediated DNA damage response
2009
Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks
2009
and 4 more

Author Peers

Author Last Decade Papers Cites
Emma Bolderson 1878 813 370 60 2.3k
Chiharu Uchida 1953 671 314 64 2.5k
Kienan I. Savage 1563 721 329 43 2.0k
Bruce C. McKay 1448 779 355 46 1.8k
Anette Sommer 1202 690 317 62 2.0k
R.E. Meyn 1396 803 463 45 2.1k
Bastiaan Evers 1720 981 366 38 2.4k
Timothy J. Jorgensen 1472 790 447 51 2.1k
Genze Shao 1779 616 321 36 2.0k
Elaine Sanij 2009 558 268 47 2.4k
Andrea Sacchetti 1178 798 398 50 2.3k

All Works

Loading papers...

Rankless by CCL
2026